Literature DB >> 26914354

Unique trophoblast stem cell- and pluripotency marker staining patterns depending on gestational age and placenta-associated pregnancy complications.

Maja Weber1, Claudia Göhner1,2, Sebastian San Martin3, Aurelia Vattai4, Stefan Hutter4, Mario Parraga3, Udo Jeschke4, Ekkehard Schleussner1, Udo R Markert1, Justine S Fitzgerald1,5.   

Abstract

Preeclampsia (PE) and intrauterine growth retardation (IUGR) are rare but severe pregnancy complications that are associated with placental insufficiency often resulting in premature birth. The clinical pathologies are related to gross placental pathologies and trophoblastic deficiencies that might derive from inflammatory processes and oxidative stress injury. The mesenchymal core of placental villi has been identified as a possible niche for trophoblast progenitor cells that are called upon to replenish the injured syncytiotrophoblast layer. These progenitor cells are known to express trophoblast stem cell (CDX2) and pluripotency (SOX2, NANOG and OCT4A) markers, however only little data is available characterizing the expression of these transcription factors beyond the blastocyst stage. We aimed to describe the expression of these factors in healthy 1st and 3rd trimester placentae as well as PE, IUGR and combined PE+IUGR placentae. We analyzed 8 respective samples derived from 1st trimester (elective abortions), and 3rd trimester (healthy controls, PE, IUGR and combined PE+IUGR). We accomplished immunoperoxidase staining to detect the stem cell markers: CDX2 (trophectoderm), SOX2, NANOG and OCT4A (embryonal). Immunoreative scoring was used for objective analyses of staining patterns. All markers display clearly elevated signals in 1st trimester villous samples as compared to healthy 3rd trimester counterparts. Especially CDX2 and NANOG were specific to the cytotrophoblast layer and the mesenchymal core. Specific and differential expression patterns were visible in the villous/extravillous compartment of each placenta-associated pregnancy complication (PE: pan elevated expression; IUGR elevated SOX2 in basal plate; combined PE+IUGR pan loss of expression). Reduction of stem cell transcription factor expression in term placentae indicates temporal regulation, and probably a specific function which is yet to be elucidated. The differential expression patterns within placentae complicated with placenta-associated pregnancy complications indicate that PE, IUGR and combined PE+IUGR are separate entities. It is unclear whether the alterations are the cause or the effect of the clinical pathology.

Entities:  

Keywords:  IUGR; placenta; pluripotency markers; preeclampsia; trophoblast stem cell markers

Mesh:

Substances:

Year:  2016        PMID: 26914354      PMCID: PMC4853049          DOI: 10.1080/19336918.2016.1142035

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  32 in total

Review 1.  Immunology of pre-eclampsia.

Authors:  Christopher W G Redman; Ian L Sargent
Journal:  Am J Reprod Immunol       Date:  2010-03-23       Impact factor: 3.886

Review 2.  Placental origins of preeclampsia: challenging the current hypothesis.

Authors:  Berthold Huppertz
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

3.  ELF5-enforced transcriptional networks define an epigenetically regulated trophoblast stem cell compartment in the human placenta.

Authors:  Myriam Hemberger; Ramya Udayashankar; Paul Tesar; Harry Moore; Graham J Burton
Journal:  Hum Mol Genet       Date:  2010-03-30       Impact factor: 6.150

4.  Expression of signal transducer and activator of transcription 3 (STAT3) and its activated forms is negatively altered in trophoblast and decidual stroma cells derived from preeclampsia placentae.

Authors:  Maja Weber; Christina Kuhn; Sandra Schulz; Barbara Schiessl; Ekkehard Schleussner; Udo Jeschke; Udo R Markert; Justine S Fitzgerald
Journal:  Histopathology       Date:  2011-12-27       Impact factor: 5.087

5.  Immunohistochemistry in human placental tissue--pitfalls of antigen detection.

Authors:  Arnd Honig; Lorenz Rieger; Michaela Kapp; Johannes Dietl; Ulrike Kämmerer
Journal:  J Histochem Cytochem       Date:  2005-07-11       Impact factor: 2.479

Review 6.  Treatment of preeclampsia: current approach and future perspectives.

Authors:  Ecaterina Berzan; Ross Doyle; Catherine M Brown
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

7.  Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome.

Authors:  Michelle K Y Siu; Esther S Y Wong; Hoi Yan Chan; Hextan Y S Ngan; Kelvin Y K Chan; Annie N Y Cheung
Journal:  Am J Pathol       Date:  2008-09-04       Impact factor: 4.307

8.  Exosomes in prostate cancer: putting together the pieces of a puzzle.

Authors:  Carolina Soekmadji; Pamela J Russell; Colleen C Nelson
Journal:  Cancers (Basel)       Date:  2013-11-11       Impact factor: 6.639

9.  Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma.

Authors:  Weiren Luo; Siyi Li; Bailu Peng; Yanfen Ye; Xubin Deng; Kaitai Yao
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

10.  Multipotent cell lineages in early mouse development depend on SOX2 function.

Authors:  Ariel A Avilion; Silvia K Nicolis; Larysa H Pevny; Lidia Perez; Nigel Vivian; Robin Lovell-Badge
Journal:  Genes Dev       Date:  2003-01-01       Impact factor: 11.361

View more
  8 in total

1.  Gal-2 Increases H3K4me3 and H3K9ac in Trophoblasts and Preeclampsia.

Authors:  Laura Hahn; Sarah Meister; Mareike Mannewitz; Susanne Beyer; Stefanie Corradini; Uwe Hasbargen; Sven Mahner; Udo Jeschke; Thomas Kolben; Alexander Burges
Journal:  Biomolecules       Date:  2022-05-15

2.  Establishment and characterization of a new human first trimester Trophoblast cell line, AL07.

Authors:  Hong Liu; Liling Wang; Yan Wang; Qian Zhu; Paulomi Aldo; Jiahui Ding; Gil Mor; Aihua Liao
Journal:  Placenta       Date:  2020-08-21       Impact factor: 3.481

3.  Micro- and Nano-vesicles from First Trimester Human Placentae Carry Flt-1 and Levels Are Increased in Severe Preeclampsia.

Authors:  Mancy Tong; Qi Chen; Joanna L James; Peter R Stone; Lawrence W Chamley
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-24       Impact factor: 5.555

4.  Alterations in antioxidant system, mitochondrial biogenesis and autophagy in preeclamptic myometrium.

Authors:  Polina A Vishnyakova; Maria A Volodina; Nadezhda V Tarasova; Maria V Marey; Natalya E Kan; Zulfiya S Khodzhaeva; Mikhail Yu Vysokikh; Gennady T Sukhikh
Journal:  BBA Clin       Date:  2017-07-03

5.  Regulation of Epigenetic Modifications in the Placenta during Preeclampsia: PPARγ Influences H3K4me3 and H3K9ac in Extravillous Trophoblast Cells.

Authors:  Sarah Meister; Laura Hahn; Susanne Beyer; Corinna Paul; Sophie Mitter; Christina Kuhn; Viktoria von Schönfeldt; Stefanie Corradini; Kritika Sudan; Christian Schulz; Theresa Maria Kolben; Sven Mahner; Udo Jeschke; Thomas Kolben
Journal:  Int J Mol Sci       Date:  2021-11-18       Impact factor: 5.923

6.  Regulatory T Cell Apoptosis during Preeclampsia May Be Prevented by Gal-2.

Authors:  Sarah Meister; Laura Hahn; Susanne Beyer; Mareike Mannewitz; Carolin Perleberg; Konstantin Schnell; David Anz; Stefanie Corradini; Elisa Schmoeckel; Doris Mayr; Uwe Hasbargen; Alaleh Zati Zehni; Sven Mahner; Udo Jeschke; Thomas Kolben
Journal:  Int J Mol Sci       Date:  2022-02-07       Impact factor: 5.923

7.  Human trophoblast stem cell self-renewal and differentiation: Role of decorin.

Authors:  Pinki Nandi; Hyobin Lim; Eloy Jose Torres-Garcia; Peeyush K Lala
Journal:  Sci Rep       Date:  2018-06-12       Impact factor: 4.379

Review 8.  Autophagy Process in Trophoblast Cells Invasion and Differentiation: Similitude and Differences With Cancer Cells.

Authors:  Lorena Carvajal; Jaime Gutiérrez; Eugenia Morselli; Andrea Leiva
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.